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ABSTRACT
Portal vein stenosis, which results in serious clinical con-
ditions such as gastrointestinal variceal bleeding and liver 
failure, is caused by hepatobiliary pancreatic cancer or 
major postoperative complications after hepatobiliary pan-
creatic surgery. In recent years, portal vein stenting under 
interventional radiology has been applied as a more useful 
treatment method for portal vein stenosis than invasive 
surgery. We herein report the successful use of a vascular 
stent for portal vein stenosis after pancreatoduodenectomy. 
A 66-year-old man with distal cholangiocarcinoma under-
went subtotal stomach-preserving pancreatoduodenecto-
my with resection of the portal vein because of direct 
invasion to the main portal vein at our hospital. The 
portal vein was reconstructed without a venous graft. He 
developed jejunal bleeding near the pancreatojejunos-
tomy on postoperative day (POD) 2. Although emboli-
zation of the responsible vessel achieved hemostasis, an 
intraoperatively inserted drainage tube was needed for a 
long period of time postoperatively because the emboli-
zed afferent jejunum was perforated. He was discharged 
on POD 39 after removal of the drainage tube. On POD 
282, he was readmitted with melena and severe fatigue. 
Computed tomography revealed an obstruction of the 
reconstructed portal vein and varices at the hepatico-
jejunostomy site. We diagnosed variceal bleeding and 
performed percutaneous transhepatic stenting in the ob-
structed portal vein. The patient was discharged in good 
clinical condition on day 15 after stenting. In conclusion, 
portal vein stenting is a useful and less invasive therapy 
for portal vein stenosis.
Key words    hepatobiliary pancreatic surgery; portal 
vein stenosis; vascular stent
Severe portal vein stenosis is caused by hepatobiliary 
pancreatic malignancies1 or major postoperative com-
plications after hepatobiliary pancreatic surgery.2 As a 
result, portal vein stenosis causes serious clinical condi-
tions such as gastrointestinal variceal bleeding and liver 
failure. Some recent reports have described the useful-
ness of portal vein stenting for postoperative portal vein 
stenosis.2, 3 In Japan, however this treatment has been 
approved as a clinical trial not a standard therapy.
 We herein report a case of successful percutaneous 
transhepatic portal stenting for portal vein stenosis with 
variceal bleeding at the hepaticojejunostomy site after 
pancreatoduodenectomy (PD). 
PATIENT REPORT
A 66-year-old man visited another hospital with a chief 
complaint of jaundice. He was diagnosed with distal 
cholangiocarcinoma and underwent endoscopic retro-
grade biliary drainage for obstructive jaundice. He was 
referred to our hospital to undergo curative resection 
for distal cholangiocarcinoma. He underwent subtotal 
stomach-preserving PD with resection of the portal vein 
because the tumor had invaded the main portal vein. The 
portal vein was directly anastomosed using 5–0 nonabsorb-
able sutures without a venous graft because of short segment 
resection of portal vein with 10 mm in length. Histological 
examination revealed well-differentiated adenocarcinoma 
invading the pancreas; however, pathological examination 
revealed no invasion into the portal vein and no lymph 
node metastases. According to the seventh edition of the 
TNM staging system of the International Union Against 
Cancer, the patient’s disease was finally diagnosed as 
distal cholangiocarcinoma, T3, N1, M0, Stage IIA. On 
postoperative day (POD) 2, He suddenly vomited a large 
amount of blood. Computed tomography (CT) revealed 
active bleeding from the vasa recta of the afferent jejunal 
loop on the mesenteric side near the pancreatojejunos-
tomy (Fig. 1). Emergency interventional radiology with 
arterial embolization to the vasa recta was successfully 
performed for hemostasis (Figs. 2A and B). However, 
the drainage tube that had been inserted intraoperatively 
was required for a long period of time because part of 
the afferent jejunum was perforated due to necrosis. The 
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Fig. 1. Computed tomography indicates extravasation from the 
afferent loop on the mesenteric side near the pancreatojejunostomy 
(arrowhead).
Fig. 2. Emergency interventional radiology for bleeding from the 
vasa recta of the afferent jejunal loop on the mesenteric side near 
the pancreatojejunostomy. (A) Arterial angiography shows extrav-
asation from the vasa recta in the jejunum near the pancreatojeju-
nostomy (arrowhead). (B) Bleeding is not shown by angiography 
after embolization (arrowhead). 
patient was discharged on POD 39 after removal of the 
drainage tube. Although the first follow-up CT after dis-
charge indicated that the reconstructed portal vein had 
been narrowed by granulation tissue around the portal 
vein (Fig. 3A), the patient was followed up because he 
was asymptomatic. On POD 82, he was readmitted to 
our hospital with severe fatigue because of a diagnosis 
of hepatic encephalopathy due to hyperammonemia. CT 
demonstrated severe stenosis of the portal vein and the 
appearance of small collateral vessels at the hepaticoje-
junostomy site (Fig. 3B). Because his clinical condition 
improved with prompt conservative therapy including 
drugs and nutritional management, he was discharged 
on POD 94 after the initial surgery. Varices at the 
hepaticojejunostomy site and fatty liver had gradually 
developed for 6 months postoperatively (Fig. 3C). He 
was then readmitted for melena and severe fatigue due to 
gastrointestinal bleeding and hyperammonemia on POD 
282. CT revealed progression of the fatty liver caused by 
decreased portal flow as well as the development of var-
ices at the hepaticojejunostomy site (Fig. 3D). Therefore, 
both to improve the recurrent symptoms caused by the 
decreased portal flow into the liver due to the obstructed 
portal vein and to prevent variceal bleeding, we per-
formed percutaneous transhepatic portal vein stenting 
using a vascular stent (S.M.A.R.T. CONTROL; Cordis, 
Tokyo, Japan), measuring 60 mm in length and 8mm in 
diameter, for stenotic portion with 20mm in length. In 
addition, embolization for the varices that had developed 
at the hepaticojejunostomy site was performed at the 
same time on POD 289 after the initial surgery, and 
portal venography revealed disappearance of the varices 
at the hepaticojejunostomy after stenting (Figs. 4A–D). 
No complications occurred during the patient’s clinical 
course. He was discharged 15 days after stenting (POD 
303 after the initial surgery). Thereafter, follow-up CT 
performed every 4 months finds no recurrence of distal 
cholangiocarcinoma and re-stenosis at the site of portal 
stent placement. His serum concentration of ammonia 
has normalized and no rebleeding has been observed.
DISCUSSION
Although portal vein resection is generally performed 
in patients with hepatobiliary pancreatic malignancies 
invading the portal vein at high-volume centers,4 portal 
vein stenosis occurs after PD with an incidence of 
2.4%.5 Severe portal vein stenosis causes life-threatening 
clinical conditions such as hepatic encephalopathy due 
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to decreased portal flow into the liver, variceal bleeding 
from the digestive tract, and ascites due to portal hyper-
tension and liver failure.6 Therefore, portal vein stenosis 
must be treated when it occurs with these complications. 
However, it is very difficult to redo a portal vein re-
construction procedure after hepatobiliary pancreatic 
surgery because of the hardened tissue around the 
reconstructed portal vein.7–9 Additionally, portosystemic 
shunting to reduce portal pressure cannot be performed 
as another procedure for benign portal stenosis because 
it aggravates hepatic encephalopathy and liver failure.7, 10 
Since the 1990s, portal vein stenting has been reported 
as a useful treatment for portal vein stenosis after liver 
transplantation or PD.3, 11 The causes of portal vein ste-
nosis after PD are not only local recurrence of malignant 
disease but also portal vein resection of ≥ 3 cm,12 gran-
ulation tissue formation associated with a postoperative 
pancreatic fistula,13 and fibrosis after radiotherapy.14–16 
In the present case, although portal vein resection was 
short segment with 10 mm in length, the portal vein 
stenosis occurred by granulation tissue formation due to 
perforation of the afferent jejunum after interventional 
radiology for active bleeding from the vasa recta on 
the mesenteric side near the pancreatojejunostomy. We 
successfully performed both percutaneous transhepatic 
portal vein stenting using a vascular stent as well as 
embolization for the varices in the hepaticojejunostomy 
site with minimal invasiveness. Embolization of varices 
at the hepaticojejunostomy site is important to ensure 
sufficient portal flow, which might maintain the patency 
Fig. 3. Follow-up computed tomography (CT) imaging after emergency interventional radiology. (A) The first follow-up CT indicates 
that the reconstructed portal vein is narrowed by a structure consisting of granulation tissue around the portal vein (arrowhead). (B) CT at 
readmission demonstrates severe stenosis of the portal vein (arrowhead) and small collateral vessels around the hepaticojejunostomy site 
(arrow). (C) Varices around the hepaticojejunostomy site (arrow) and fatty liver had gradually have developed for 6 months after surgery. (D) 
CT at the second readmission shows both progression of the fatty liver caused by the decreased portal flow as well as the development of 
varices around the hepaticojejunostomy site.
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of the portal stent.17, 18 The usefulness and efficacy of an-
ticoagulant therapy after portal vein stenting is unclear. 
While anticoagulant therapy is reportedly useful to 
maintain the patency of the portal vein stent,19 sufficient 
portal flow by embolization of collaterals is reported the 
importance for maintenance of the patency of the portal 
vein stent.17, 18 Furthermore, Kato et al. reported that the 
presence of a collateral vein is the only variable related 
to the development of stent occlusion.20 
 In the present case, the patient had previously under-
gone pacemaker implantation for sick sinus syndrome 
and had continued anticoagulant therapy before surgery. 
Therefore, whether anticoagulant therapy was required 
after portal stenting remains unclear in this case. 
 In conclusion, portal vein stenting is a useful and 
less invasive therapy for portal vein stenosis after PD. 
Therefore, approval of this procedure should be con-
sidered as a standard therapy for portal vein stenosis in 
Japan.
Ethics approval and consent to participate: Consent for publica-
tion was obtained from the patient. 
The authors declare no conflict of interest.
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